Loading...
XNYSCVS
Market cap55bUSD
Dec 24, Last price  
44.16USD
1D
0.05%
1Q
-24.69%
Jan 2017
-44.04%
Name

CVS Health Corp

Chart & Performance

D1W1MN
XNYS:CVS chart
P/E
6.66
P/S
0.16
EPS
6.63
Div Yield, %
5.64%
Shrs. gr., 5y
4.32%
Rev. gr., 5y
12.95%
Revenues
357.78b
+11.24%
30,594,300,00037,006,200,00043,813,800,00076,329,500,00087,471,900,00098,729,000,00096,413,000,000107,100,000,000123,133,000,000126,761,000,000139,367,000,000153,290,000,000177,526,000,000184,765,000,000194,579,000,000256,776,000,000268,706,000,000292,111,000,000321,629,000,000357,776,000,000
Net income
8.34b
+93.55%
918,800,0001,224,700,0001,368,900,0002,637,000,0003,212,100,0003,696,000,0003,427,000,0003,461,000,0003,877,000,0004,592,000,0004,644,000,0005,237,000,0005,317,000,0006,622,000,000-594,000,0006,634,000,0007,179,000,0008,001,000,0004,311,000,0008,344,000,000
CFO
13.43b
-17.01%
914,200,0001,612,100,0001,742,400,0003,229,700,0003,947,100,0004,035,000,0004,779,000,0005,856,000,0006,671,000,0005,783,000,0008,137,000,0008,412,000,00010,069,000,0008,007,000,0008,865,000,00012,848,000,00015,865,000,00018,265,000,00016,177,000,00013,426,000,000
Dividend
Oct 21, 20240.665 USD/sh
Earnings
Feb 05, 2025

Profile

CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Its Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company's Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. As of December 31, 2021, it operated approximately 9,900 retail locations and 1,200 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
URL
https://cvshealth.com/
IPO date
Oct 01, 1952
Employees
219,000
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
357,776,000
11.24%
321,629,000
10.11%
292,111,000
8.71%
Cost of revenue
303,345,000
305,887,000
276,997,000
Unusual Expense (Income)
NOPBT
54,431,000
15,742,000
15,114,000
NOPBT Margin
15.21%
4.89%
5.17%
Operating Taxes
2,805,000
1,509,000
2,522,000
Tax Rate
5.15%
9.59%
16.69%
NOPAT
51,626,000
14,233,000
12,592,000
Net income
8,344,000
93.55%
4,311,000
-46.12%
8,001,000
11.45%
Dividends
(3,132,000)
(2,907,000)
(2,625,000)
Dividend yield
3.07%
2.36%
1.91%
Proceeds from repurchase of equity
(2,012,000)
(2,949,000)
381,000
BB yield
1.98%
2.39%
-0.28%
Debt
Debt current
4,713,000
3,456,000
5,851,000
Long-term debt
92,447,000
85,754,000
89,971,000
Deferred revenue
5,087,000
Other long-term liabilities
14,920,000
16,068,000
8,306,000
Net debt
62,686,000
52,391,000
60,272,000
Cash flow
Cash from operating activities
13,426,000
16,177,000
18,265,000
CAPEX
(3,031,000)
(2,727,000)
(2,520,000)
Cash from investing activities
(20,889,000)
(5,047,000)
(5,261,000)
Cash from financing activities
2,683,000
(10,516,000)
(11,356,000)
FCF
57,048,000
15,064,000
15,857,000
Balance
Cash
11,455,000
15,723,000
12,525,000
Long term investments
23,019,000
21,096,000
23,025,000
Excess cash
16,585,200
20,737,550
20,944,450
Stockholders' equity
110,474,000
103,173,000
103,554,000
Invested Capital
154,355,800
137,377,450
143,828,550
ROIC
35.39%
10.12%
8.55%
ROCE
31.06%
9.72%
8.84%
EV
Common stock shares outstanding
1,290,000
1,323,000
1,329,000
Price
78.96
-15.27%
93.19
-9.66%
103.16
51.04%
Market cap
101,858,400
-17.38%
123,290,370
-10.07%
137,099,640
52.76%
EV
164,719,400
175,981,370
197,677,640
EBITDA
58,797,000
19,989,000
19,626,000
EV/EBITDA
2.80
8.80
10.07
Interest
2,658,000
2,287,000
2,503,000
Interest/NOPBT
4.88%
14.53%
16.56%